4//SEC Filing
Chang David D 4
Accession 0001214659-21-005927
CIK 0001737287other
Filed
May 25, 8:00 PM ET
Accepted
May 26, 8:00 AM ET
Size
9.4 KB
Accession
0001214659-21-005927
Insider Transaction Report
Form 4
Chang David D
DirectorPresident and CEO
Transactions
- Exercise/Conversion
Common Stock
2021-05-24$18.22/sh+27,410$499,410→ 2,312,279 total - Exercise/Conversion
Stock Option (Right to Buy)
2021-05-24−27,410→ 541,190 totalExercise: $18.22Exp: 2030-03-18→ Common Stock (27,410 underlying)
Holdings
- 1,201,108(indirect: See footnote)
Common Stock
- 856,044(indirect: See footnote)
Common Stock
- 856,044(indirect: See footnote)
Common Stock
Footnotes (4)
- [F1]Securities held in the name of the Chang 2006 Family Trust.
- [F2]Securities held in the name of the JEC 2019 Trust dated October 1, 2019.
- [F3]Securities held in the name of the RTC 2019 Trust dated October 1, 2019.
- [F4]25% of the shares subject to the stock option shall vest on the first anniversary of the grant date, and the remaining shares shall vest in 36 equal monthly installments thereafter.
Documents
Issuer
Allogene Therapeutics, Inc.
CIK 0001737287
Entity typeother
Related Parties
1- filerCIK 0001611024
Filing Metadata
- Form type
- 4
- Filed
- May 25, 8:00 PM ET
- Accepted
- May 26, 8:00 AM ET
- Size
- 9.4 KB